pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,081 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1024Endpoints778BioPharma Dive297BioSpace214Fierce Biotech203onclive165raps74globenewswire health
therapy area
allOncology6027Rare Disease1434Cardiology1089Hematology1024Immunology1000Vaccines902Pulmonology
  • Danske Bank corrects webpage to place English PDF in English section
    A correction has been issued for a previous notification concerning Danske Bank A/S. The original posting attached both Danish and English PDF files under the Danish version of the page. The corre…
    globenewswire health · 15d agoNeutral↗ source
  • Danske Bank corrects webpage to place English PDF under English version
    In a recent update, Danske Bank clarified a mistake on its transaction reporting page. The original notice had both the Danish and English PDF documents linked under the Danish version of the site.…
    globenewswire health · 15d agoNeutral↗ source
← prev
page 7 of 44
next →
73
fda recalls47
fda medwatch37
fda press28
899
Psychiatry & CNS712
Ophthalmology421
Endocrinology & Metabolism380
Pain373
Infectious Disease354
Danske Bank corrects website to relocate English PDF to appropriate page
Danske Bank issued a correction notice indicating that an English PDF document has been moved to the English version of its website. The original announcement had attached both Danish and English…
globenewswire health · 15d agoNeutral↗ source
  • Correction: English PDF for Danske Bank transaction disclosures moved to English webpage
    A correction notice has been issued for a Danske Bank disclosure on transactions by persons with managerial responsibilities. The update concerns the location of the English language PDF on the ban…
    globenewswire health · 15d agoNeutral↗ source
  • Danske Bank corrects placement of English PDF in transaction disclosure
    A correction notice was issued for Danske Bank A/S concerning the location of an English PDF file in its public disclosure. The original announcement had both the Danish and English PDFs attached…
    globenewswire health · 15d agoRegulatoryNeutral↗ source
  • Danske Bank corrects webpage to place English PDF in English section
    A correction has been issued for a Danske Bank notification concerning the placement of PDF documents on its website. The original posting attached both the Danish and English versions of the PDF…
    globenewswire health · 15d agoNeutral↗ source
  • Danske Bank discloses share sales by APMH Invest under its buyback program
    On August 5, 2026, Danske Bank A/S filed a market‑abuse regulation report detailing changes in share ownership among its reporting persons. The filing notes that APMH Invest A/S, a shareholder, so…
    globenewswire health · 15d agoRegulatoryNeutral↗ source
  • Danske Bank reports manager share transactions linked to ongoing buy-back program
    Danske Bank A/S filed a notification under the EU Market Abuse Regulation, disclosing transactions made by persons with managerial responsibilities. The filing notes that APMH Invest A/S is contin…
    globenewswire health · 15d agoRegulatoryNeutral↗ source
  • Danske Bank reports share sale by APMH Invest under its buyback program
    Danske Bank A/S filed a regulatory disclosure on 5 August 2026 detailing a change in shareholdings linked to its EU‑mandated market‑abuse reporting requirements. APMH Invest A/S sold shares of Dan…
    globenewswire health · 15d agoRegulatoryNeutral↗ source
  • Danske Bank reports ongoing share buy-back sales by APMH Invest under regulatory disclosure
    On 5 August 2026 Danske Bank A/S filed a notification under the EU Market Abuse Regulation describing transactions by persons required to report to the Danish FSA and Nasdaq Copenhagen. The bank d…
    globenewswire health · 15d agoRegulatoryNeutral↗ source
  • Danske Bank corrects website to move English PDF to English page
    Danske Bank issued a correction notice about the placement of its PDF documents on its website. The original posting attached both the Danish and English PDFs under the Danish version of the page.…
    globenewswire health · 15d agoNeutral↗ source
  • Otsuka's Voyxact hits key secondary endpoint in Phase 3 IgA nephropathy trial as BioNTech cuts revenue outlook
    Otsuka announced that its experimental kidney drug Voyxact met a key secondary endpoint in the Phase 3 VISIONARY study of patients with IgA nephropathy. The positive result suggests the therapy ha…
    Endpoints · 16d agoPositive readoutNeutral↗ source
  • Pathos AI signs major ADC partnership with Chinese biotech Alphamab and targets up to $300M Series E raise
    Pathos AI, a technology and drug development company, announced a major antibody‑drug conjugate (ADC) collaboration with Chinese biotech Alphamab. The firm also disclosed a partnership with AstraZ…
    Endpoints · 16d agoDealPositive↗ source
  • Hinge Health to acquire Cylinder Health for $105 million, expanding into digestive care
    Hinge Health, known for virtual physical therapy, announced it will purchase digestive health startup Cylinder Health. The transaction is a cash deal valued at $105 million, marking Hinge's latest…
    Endpoints · 15d agoDealPositive↗ source
  • Pfizer CEO says company has already completed its largest deals, no further acquisitions planned
    Pfizer chief Albert Bourla addressed investors from the New York Stock Exchange floor, noting that the company has already executed its biggest transactions and has roughly $6 billion earmarked for…
    Endpoints · 16d agoDealNeutral↗ source
  • Ambient scribing startups draw attention as Abridge secures $300 million funding
    Last summer, a wave of ambient scribing startups captured the health-tech spotlight. These companies employ artificial-intelligence systems that listen to doctor-patient conversations and automati…
    Endpoints · 16d agoDealNeutral↗ source
  • Akido expands AI-driven patient intake and diagnostic tools to 100 clinics
    Akido, a health‑technology startup, announced it will deploy its artificial‑intelligence platform for patient intake and diagnostic assistance in 100 clinics. The AI system captures patient inform…
    Endpoints · 16d agoDealPositive↗ source
  • Bayer plans German launch of new stroke drug despite healthcare spending cuts
    Bayer announced it will move forward with the launch of its new stroke medication in Germany. The decision comes even though Germany has introduced a new healthcare spending bill that reduces reim…
    Endpoints · 16d agoNeutral↗ source
  • Merck's anti-TL1A antibody shows benefit in hidradenitis suppurativa but misses endpoint in rare lung disease trial
    Merck reported mixed results from its anti‑TL1A antibody, a product of its $10.8 billion acquisition of Prometheus Biosciences. In a mid‑stage study for hidradenitis suppurativa, the antibody met…
    Endpoints · 16d agoNeutral↗ source
  • AstraZeneca and Bristol Myers Squibb rumored to be in talks for a major merger
    Over the weekend, reports emerged that AstraZeneca and Bristol Myers Squibb were reportedly discussing a possible merger. Industry observers note that such a combination would create one of the la…
    Endpoints · 16d agoDealNeutral↗ source
  • Merck to test experimental sac-TMT antibody-drug conjugate with Keytruda in lung cancer trial
    Merck announced it will start a clinical trial testing its experimental antibody-drug conjugate sac-TMT together with the immunotherapy Keytruda in patients with lung cancer. The study will assess…
    Endpoints · 16d agoNeutral↗ source
  • Pfizer adds $2.5 billion to cost-cutting plan, pushing total savings past $10 billion
    Pfizer announced on Tuesday an additional $2.5 billion of cost reductions across the company, extending its multi-year austerity program. The new cuts bring the cumulative savings effort to more t…
    Endpoints · 16d agoNegative↗ source
  • US-China biotech rivalry sparks calls for deeper discussion, says editor
    The editor notes that the ongoing debate over the competitive relationship between U.S. and Chinese biotechnology sectors has been unfolding over recent months. While many knowledgeable voices are…
    Endpoints · 16d agoNegative↗ source
  • Early Alert: Intraosseous Needle Set Issue from Becton Dickinson
    BD is recalling certain BD Intraosseous Vascular Access System Needle Sets due to difficulty removing the obturator (stylet) following placement.
    fda medwatch · 16d agoRegulatoryNeutral↗ source
  • Amgen drops early-stage obesity drug candidate AMG-513
    Amgen announced it is discontinuing its early-stage obesity candidate AMG-513. The program was in Phase 1, but the company provided no details about the study or the reasons for the halt. A spokes…
    Endpoints · 15d agoNegative↗ source